Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Waters Corporation (NYSE:WAT). In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Waters stock on August 12th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 9/2/2025.
- Sold $1,001 - $15,000 in shares of Chart Industries NYSE: GTLS on 9/2/2025.
- Purchased $1,001 - $15,000 in shares of Avient NYSE: AVNT on 9/2/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 8/27/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Intapp NASDAQ: INTA on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Waters NYSE: WAT on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 8/26/2025.
- Sold $1,001 - $15,000 in shares of Fortive NYSE: FTV on 8/26/2025.
Waters Stock Performance
Shares of NYSE WAT traded down $4.95 during trading hours on Friday, reaching $301.43. The stock had a trading volume of 2,012,717 shares, compared to its average volume of 586,122. The business's fifty day moving average is $294.95 and its two-hundred day moving average is $330.89. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The company has a market cap of $17.94 billion, a price-to-earnings ratio of 27.18, a PEG ratio of 2.86 and a beta of 1.07. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.
Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. The company had revenue of $771.33 million for the quarter, compared to analysts' expectations of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business's revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, research analysts expect that Waters Corporation will post 12.86 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on WAT shares. Robert W. Baird reduced their target price on Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Wall Street Zen cut Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a "buy" rating in a report on Monday, August 4th. UBS Group reiterated a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Finally, Bank of America lifted their price objective on Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $378.73.
View Our Latest Analysis on Waters
Institutional Investors Weigh In On Waters
A number of large investors have recently added to or reduced their stakes in the business. Brighton Jones LLC grew its holdings in shares of Waters by 112.9% during the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock worth $471,000 after purchasing an additional 673 shares in the last quarter. Captrust Financial Advisors raised its position in Waters by 2.7% in the fourth quarter. Captrust Financial Advisors now owns 2,822 shares of the medical instruments supplier's stock valued at $1,047,000 after purchasing an additional 75 shares during the last quarter. Cetera Investment Advisers raised its position in shares of Waters by 4.0% during the fourth quarter. Cetera Investment Advisers now owns 4,087 shares of the medical instruments supplier's stock worth $1,516,000 after acquiring an additional 158 shares during the last quarter. D. E. Shaw & Co. Inc. grew its stake in Waters by 94.9% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 9,550 shares of the medical instruments supplier's stock worth $3,543,000 after purchasing an additional 4,651 shares during the period. Finally, Focus Partners Wealth grew its stake in Waters by 2.4% in the fourth quarter. Focus Partners Wealth now owns 6,942 shares of the medical instruments supplier's stock valued at $2,677,000 after acquiring an additional 165 shares during the period. Institutional investors own 94.01% of the company's stock.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Waters Company Profile
(
Get Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.